Slingshot members are tracking this event:
Phase 1b COSMIC-021 Trial data of Exelixis'(EXEL) Cabozantinib + atezolizumab (TECENTRIQ) in Solid tumors to be presented February 13, 2020 at ASCO GU
Slingshot Insights Explained
Feb 10, 2020
Don’t see a project related to the catalyst you care about?
Related Keywords Cabozantinib, Atezolizumab, Tecentriq, Solid Tumors